The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients
Clinical trial NCT07015021 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07015021
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-09-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.